The nuclear receptor superfamily comprises the largest known group of transcription factors, members of which are found exclusively in metazoans.
nhr-6 is one of the 210 nuclear receptor genes present in C. elegans (see abstract by Lindblom, et.al.). The apparent homology of
nhr-6 to the vertebrate nerve growth factor induced protein B (NGFI-B) family of orphan receptors identifies
nhr-6 as one of the few C. elegans nuclear receptor genes that fall into NR classes conserved between vertebrates and invertebrates. This conservation implicates
nhr-6 as an ancient member of the NR superfamily, indicating potentially conserved and important functions. Furthermore, the presence of an
nhr-6 homologue in the parasitic dog heart worm, Dirofilaria immitis, suggests that information pertaining to the biology of D. immitis could be gained via studies of
nhr-6 function. In order to gain initial insight into the function of the
nhr-6 gene product, we have utilized RNAi to disrupt gene function. The results indicate that
nhr-6 may perform roles in both hermaphrodite gonad development and embryogenesis. In F1 progeny from injected parents, we observed high-penetrance gonadal defects, abnormal oocyte development, and a low but reproducible incidence of embryonic lethality. As has been reported for several other genes, the RNAi effects were also observed in the F2 and F3 generations. The
nhr-6 temporal expression profile obtained by Northern analysis and RT-PCR is consistent with the view that
nhr-6 functions in embryogenesis and gonad development.
nhr-6 mRNA is present in all developmental stages, with the highest expression levels in the embryo and the adult. We have observed the first specific mutant phenotype for the conserved class of NGFI-B nuclear receptors, as knockouts of the mouse NGFI-B gene yielded apparently normal animals. The lack of an observable phenotype in the NGFI-B knockout animals is most likely due to redundancy of function with the highly similar NOR1 and Nurr1 genes. Efforts to obtain
nhr-6 mutants for further characterization are underway. Additionally, the construction of an
nhr-6::GFP fusion gene and the production of anti-NHR-6 antibodies for spatial expression studies are in progress.